Literature DB >> 7508895

Inhibition of gastrin-induced proliferation of AR4-2J cells by calcium channel antagonists.

V Bertrand1, M J Bastié, N Vaysse, L Pradayrol.   

Abstract

The exact intracellular mechanisms by which gastrin enhances the proliferation of AR4-2J cells, a tumor pancreatic acinar cell line, are not precisely known. Calcium has long been considered as an intracellular signal involved in growth-regulatory control of many cell types. Moreover, Ca++ channel blockers show growth-suppressing effects in most proliferating cells. In the present study, we analyzed the role of nifedipine, a voltage-dependent Ca++ channel antagonist, on AR4-2J cells which possess well-defined voltage-dependent Ca++ channels. The results showed that 10 nM gastrin induced a transient rise in intracellular calcium (Ca++)i followed by a sustained phase which was dependent upon a Ca++ influx operating through nifedipine-dependent and -independent Ca++ channels. Both influxes are necessary for reloading the agonist-sensitive Cai++ pools. In parallel, we demonstrated that nifedipine at doses of 1 microM and 3 microM preferentially blocked the increase in cell number elicited by 10 nM gastrin and 0.1 microM Bay K 8644, a Ca++ channel agonist, suggesting that voltage-sensitive Ca++ channel activity was required for gastrin-stimulated mitogenesis. Moreover, nifedipine had no effect on the proliferation of AR4-2J cells growing in serum-free medium, indicating that this drug did not simply exert a toxic effect. Therefore, Ca++ influx through voltage-dependent Ca++ channels might be an important initial step representing a component of a synergistic cooperation between different signal transduction pathways involved in gastrin-regulated growth.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508895     DOI: 10.1002/ijc.2910560324

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms.

Authors:  L Buscail; J P Estève; N Saint-Laurent; V Bertrand; T Reisine; A M O'Carroll; G I Bell; A V Schally; N Vaysse; C Susini
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

2.  CacyBP/SIP nuclear translocation induced by gastrin promotes gastric cancer cell proliferation.

Authors:  Hui-Hong Zhai; Juan Meng; Jing-Bo Wang; Zhen-Xiong Liu; Yuan-Fei Li; Shan-Shan Feng
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

3.  Ca2+ and protein kinase C-dependent mechanisms involved in gastrin-induced Shc/Grb2 complex formation and P44-mitogen-activated protein kinase activation.

Authors:  L Daulhac; A Kowalski-Chauvel; L Pradayrol; N Vaysse; C Seva
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

Review 4.  Cav1.2, cell proliferation, and new target in atherosclerosis.

Authors:  Nikolai M Soldatov
Journal:  ISRN Biochem       Date:  2013-05-12

5.  CacyBP/SIP promotes the proliferation of colon cancer cells.

Authors:  Huihong Zhai; Yongquan Shi; Xiong Chen; Jun Wang; Yuanyuan Lu; Faming Zhang; Zhengxiong Liu; Ting Lei; Daiming Fan
Journal:  PLoS One       Date:  2017-02-14       Impact factor: 3.240

Review 6.  The prince and the pauper. A tale of anticancer targeted agents.

Authors:  Alfonso Dueñas-González; Patricia García-López; Luis Alonso Herrera; Jose Luis Medina-Franco; Aurora González-Fierro; Myrna Candelaria
Journal:  Mol Cancer       Date:  2008-10-23       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.